Miller Steve bought CPRX
August 26, 2025 · Form 4 insider transaction
Miller Steve bought 115,000 shares of Catalyst Pharmaceuticals Inc at $2.24 per share, a transaction worth $257.6K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
115,000
Price
$2.24
Total value
$257.6K
InsiderMiller Steve
Role—
SecurityCommon stock, par value $0.001 per share
Transaction codeM: Option exercise
Transaction dateAugust 26, 2025
Filing dateAugust 28, 2025
Shares owned after1,064,663
OwnershipDirect
10b5-1 planNo
AmendedNo